[Results of directed cytoctatic therapy for ovarian cancer].
The paper presents the comparison of the results of individualized postoperative chemotherapy and non-individualized treatment with Trenimon in ovarian cancer patients. Individual treated patients had a mean survival time of 9.7 months and the other group only 9.4 months, that means, there are no significant differences between the two treatment groups.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008722:Methods; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000601:surgery; D011182:Postoperative Care; D011379:Prognosis
D000970:Antineoplastic Agents
Ergebnisse einer gezielten zytostatischen Behandlung des Ovarialkarzinoms.